Plasma homocysteine levels in renal transplant patients on tacrolimus therapy

Transplantation Proceedings

Volumn 36, Issue 1, 2004, Pages 159-160

  Akbas, S H ^a   Tuncer, M ^a   Gurkan, A ^a   Yucetin, L ^a   Yavuz, A ^a   Demirbas, A ^a   Ersoy, F ^a   Gultekin, M ^a   Yakupoglu, G ^b   Akaydin, M ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

^b Department of Nephrology ^*

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; TACROLIMUS;

ADULT; AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; CADAVER; CARDIOVASCULAR RISK; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE MARKER; DRUG EFFECT; FEMALE; FOLIC ACID BLOOD LEVEL; HUMAN; HYPERHOMOCYSTEINEMIA; KIDNEY FUNCTION; KIDNEY GRAFT; MALE; PRIORITY JOURNAL; RECIPIENT; VITAMIN BLOOD LEVEL;

EID: 0842324787     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2003.11.059     Document Type: Conference Paper

References (9)

1. Stein G., Muller A., Busch M., et al. Homocysteine, its metabolites, and B group vitamins in renal transplant patients. Kidney Int. 59:(Suppl 78):2001;262.
2. Quirogo I., Morris-Stiff G., Baboo R., et al. Differential homocysteine levels in renal transplant patients receiving neoral versus tacrolimus. Transplant Proc. 33:2001;1209.
3. Ueland P.M. Homocysteine species as components of plasma redox thiol status. Clin Chem. 41:1995;340.
4. Boushey C.J., Beresford S.A.A., Omenn G.S., et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA. 274:1995;1049.
5. Arnadottir M., Hultberg B., Vladov V., et al. Hyperhomocysteinemia in cyclosporin treated renal transplant recipients. Transplantation. 65:1998;544.
6. Cole D.E., Ross H.J., Evrovski J., et al. Correlation between total homocysteine and cyclosporine concentrations in cardiac transplant recipients. Clin Chem. 44:1998;2307.
7. Artz M.A., Boots J.M.M., Ligtenberg G. Randomized conversion from cyclosporine to tacrolimus in renal transplant patients improved lipid profile and unchanged plasma homocysteine levels . Transplant Proc. 34:2002;1793.
8. Ducloux D., Ruedin C., Gibey R., et al. Prevalance, determinants and clinical significance of hyperhomocysteinemia in renal transplant recipients. Nephrol Dial Transplant. 13:1998;2890.
9. Ignatescu M.C., Kletzmayr J., Fodinger M., et al. Influence of mycophenolic acid and tacrolimus on homocysteine metabolism. Kidney Int. 61:2002;1894.